Movement Disorders

Cover image for Movement Disorders

Special Issue: Basic and Therapeutic Aspects of Neurotoxins

March 2004

Volume 19, Issue S8

Pages S1–S167

Issue edited by: Hans Bigalke, Dirk Dressler, Joseph Jankovic

  1. Introduction

    1. Top of page
    2. Introduction
    3. Research Articles
    1. Basic and therapeutic aspects of neurotonins (page S1)

      Hans Bigalke, Dirk Dressler and Joseph Jankovic

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20002

  2. Research Articles

    1. Top of page
    2. Introduction
    3. Research Articles
    1. Molecular targets of botulinum toxin at the mammalian neuromuscular junction (pages S7–S16)

      Dorothy D. Whelchel, Tonia M. Brehmer, Paula M. Brooks, Neely Darragh and Julie A. Coffield

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20004

    2. Structure and enzymatic activity of botulinum neurotoxins (pages S17–S22)

      Subramanyam Swaminathan, Subramanian Eswaramoorthy and Desigan Kumaran

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20005

    3. Is the light chain subcellular localization an important factor in botulinum toxin duration of action? (pages S23–S34)

      Ester Fernández-Salas, Helen Ho, Patton Garay, Lance E. Steward and K. Roger Aoki

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20006

    4. Retargeted clostridial endopeptidases: Inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain (pages S42–S47)

      John A. Chaddock, John R. Purkiss, Frances C.G. Alexander, Sarah Doward, Sarah J. Fooks, Lorna M. Friis, Yper H.J. Hall, Elizabeth R. Kirby, Nicola Leeds, Hilary J. Moulsdale, Anthony Dickenson, G. Mark Green, Wahida Rahman, Rie Suzuki, Michael J. Duggan, Conrad P. Quinn, Clifford C. Shone and Keith A. Foster

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20008

    5. Roads from vaccines to therapies (pages S48–S52)

      Leonard A. Smith, Melody J. Jensen, Vicki A. Montgomery, Douglas R. Brown, S. Ashrat Ahmed and Theresa J. Smith

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20009

    6. Different types of botulinum toxin in humans (pages S53–S59)

      Roberto Eleopra, Valeria Tugnoli, Rocco Quatrale, Ornella Rossetto and Cesare Montecucco

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20010

    7. Central effects of botulinum toxin type A: Evidence and supposition (pages S60–S64)

      Antonio Currà, Carlo Trompetto, Giovanni Abbruzzese and Alfredo Berardelli

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20011

    8. Detection of antibodies against botulinum toxins (pages S85–S91)

      Dorothea Sesardic, Russell G.A. Jones, Tong Leung, Toni Alsop and Robert Tierney

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20021

    9. Clinical comparability of marketed formulations of botulinum toxin (pages S129–S136)

      Cristina Sampaio, João Costa and Joaquim J. Ferreira

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20066

    10. Botulinum toxin treatment of secretory disorders (pages S137–S141)

      Markus Naumann and Wolfgang Jost

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20067

    11. Botulinum toxin in neuro-urological disorders (pages S142–S145)

      Wolfgang H. Jost and Markus Naumann

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20068

    12. Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms (pages S146–S156)

      Giuseppe Brisinda, Anna Rita Bentivoglio, Giorgio Maria and Alberto Albanese

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20070

    13. New therapeutic indications for botulinum toxins (pages S157–S161)

      Carla Cordivari, V. Peter Misra, Santiago Catania and Andrew J. Lees

      Version of Record online: 9 MAR 2004 | DOI: 10.1002/mds.20071

SEARCH

SEARCH BY CITATION